Hepatitis E primary prevention

Revision as of 19:38, 4 December 2012 by Maheep Sangha (talk | contribs)
Jump to navigation Jump to search

Hepatitis E Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Hepatitis E from other Diseases

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Hepatitis E primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatitis E primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatitis E primary prevention

CDC on Hepatitis E primary prevention

Hepatitis E primary prevention in the news

Blogs on Hepatitis E primary prevention

Directions to Hospitals Treating Hepatitis E

Risk calculators and risk factors for Hepatitis E primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Prevention

Improving sanitation is the most important measure, which consists in proper treatment and disposal of human waste, higher standards for public water supplies, improved personal hygiene procedures and sanitary food preparation. Thus, prevention strategies of this disease are similar to those of many others that plague developing nations, and they require large-scale international financing of water supply and water treatment projects. A vaccine based on recombinant viral proteins has been developed and recently tested in a high-risk population (military personnel of a developing country).[1] The vaccine appeared to be effective and safe, but further studies are needed to assess the long-term protection and the cost-effectiveness of hepatitis E vaccination.

Guidelines for Epidemic Measures

  • Determination of the mode of transmission.
  • Identification of the population exposed to increased risk of infection.
  • Elimination of a common source of infection.
  • Improvement of sanitary and hygienic practices to eliminate faecal contamination of food and water.

References

  1. Shrestha MP, Scott RM, Joshi DM; et al. (2007). "Safety and efficacy of a recombinant hepatitis E vaccine". N. Engl. J. Med. 356 (9): 895–903. doi:10.1056/NEJMoa061847. PMID 17329696.

Template:WS Template:WH